Premium
Combined type‐1 plasminogen activator inhibitor and NOD2/CARD15 genotyping predicts complicated Crohn's disease behaviour
Author(s) -
ALVAREZLOBOS M.,
AROSTEGUI J. I.,
SANS M.,
TASSIES D.,
PIU J.,
REVERTER J. C.,
PIQUE J. M.,
YAGÜE J.,
PANÉS J.
Publication year - 2007
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/j.1365-2036.2006.03208.x
Subject(s) - crohn's disease , nod2 , genotyping , medicine , genotype , multivariate analysis , gastroenterology , plasminogen activator , disease , plasminogen activator inhibitor 1 , gene , biology , genetics
Summary Background NOD2/CARD15 gene variants have not been universally associated with stricturing behaviour in Crohn's disease. Other behaviour modifying genes could explain these results. Aim To study the combined influence of NOD2/CARD15 variants and 4G/4G genotype of type‐1 plasminogen activator inhibitor (PAI‐1) gene on Crohn's disease behaviour. Methods One hundred and seventy Crohn's disease patients were studied prospectively, with a mean follow‐up of 7± 6 years. Disease behaviour was registered by using two criteria: the Vienna classification and a non‐hierarchical classification based on the behavioural Vienna categories. Results In the multivariate analysis for stricturing behaviour according to the Vienna categories, only absence of colonic disease (OR, 4.0; 95% CI: 1.49–11.1; P = 0.006) was an independent predictive factor. However, in the multivariate analysis for stricturing disease applying a non‐hierarchical criteria, ileal disease (OR, 4.19; 95% CI: 1.30–13.5; P = 0.01), and carrying both NOD2/CARD15 variants and the 4G/4G PAI‐1 genotype (OR, 5.02; 95% CI: 1.44–17.48; P = 0.01) were independent predictive factors. In the multivariate analysis for penetrating behaviour, the 4G/4G PAI‐1 (OR, 3.10; 95% CI: 1.54–6.23; P = 0.001) and male sex (OR, 2.44; 95% CI: 1.30–4.60; P = 0.005) were independent predictive factors irrespective of criteria applied. Conclusions Combined PAI‐1 and NOD2/CARD15 genotyping predict complicated Crohn's disease. Patients with these variants could benefit from early interventions.